Although a direct activity of Il33 in enhancing cardiomyocyte proliferation has never been reported so far, its capacity to foster the growth and metastatic invasion of at least some cancer types, including non-small-cell lung cancer (NSCLC)27, epithelial ovarian cancer28, breast cancer29, and glioma30. This evidence concerns the gene IL33 and non-small cell lung carcinoma.